CLINICAL_TRIALS
trial_result
· 2011-07-15
Clinical Trial Update: Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 trial evaluating bevacizumab with erlotinib in inoperable and metastatic hepatocellular carcinoma completed with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arkansas | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2011-07-15